Mesothelioma
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chimeric HLA-A*02:01 (mα3) &mB2M&MAGE-A2 (KMVELVHFL) Monomer Protein (MHC-HM104) | Login | Chimeric HLA-A*02:01 (mα3) &mB2M&MAGE-A2 (KMVELVHFL) Monomer Protein (MHC-HM104) | ||||||||||||||||
|
||||||||||||||||||
| Chimeric HLA-A*02:01 (mα3) &mB2M&MAGE-A1 (KVLEYVIKV) Monomer Protein (MHC-HM103) | Login | Chimeric HLA-A*02:01 (mα3) &mB2M&MAGE-A1 (KVLEYVIKV) Monomer Protein (MHC-HM103) | ||||||||||||||||
|
||||||||||||||||||
| Chimeric HLA-A*02:01 (mα3) &mB2M&NY-ESO-1 (SLLMWITQC) Monomer Protein (MHC-HM151) | Login | Chimeric HLA-A*02:01 (mα3) &mB2M&NY-ESO-1 (SLLMWITQC) Monomer Protein (MHC-HM151) | ||||||||||||||||
|
||||||||||||||||||
| Chimeric HLA-A*02:01 (mα3) &mB2M&GP100 (YLEPGPVTA) Monomer Protein (MHC-HM150) | Login | Chimeric HLA-A*02:01 (mα3) &mB2M&GP100 (YLEPGPVTA) Monomer Protein (MHC-HM150) | ||||||||||||||||
|
||||||||||||||||||
| APC-equivalent Human HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Tetramer Protein (MHC-HM10BTC) | Login | APC-equivalent Human HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Tetramer Protein (MHC-HM10BTC) | ||||||||||||||||
|
||||||||||||||||||
| APC-equivalent Human Peptide Ready HLA-A*11:01&B2M Tetramer Protein (MHC-HM41RTC) | Login | APC-equivalent Human Peptide Ready HLA-A*11:01&B2M Tetramer Protein (MHC-HM41RTC) | ||||||||||||||||
|
||||||||||||||||||
| FITC-equivalent Human Peptide Ready HLA-A*11:01&B2M Tetramer Protein (MHC-HM41RTF) | Login | FITC-equivalent Human Peptide Ready HLA-A*11:01&B2M Tetramer Protein (MHC-HM41RTF) | ||||||||||||||||
|
||||||||||||||||||
| FITC-equivalent Human Peptide Ready HLA-A*03:01&B2M Tetramer Protein (MHC-HM44RTF) | Login | FITC-equivalent Human Peptide Ready HLA-A*03:01&B2M Tetramer Protein (MHC-HM44RTF) | ||||||||||||||||
|
||||||||||||||||||
| FITC-equivalent Human Peptide Ready HLA-A*02:01&B2M Tetramer Protein (MHC-HM43RTF) | Login | FITC-equivalent Human Peptide Ready HLA-A*02:01&B2M Tetramer Protein (MHC-HM43RTF) | ||||||||||||||||
|
||||||||||||||||||
| mouse anti-human Mps1 | Login | mouse anti-human Mps1 | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human MLH1 Antibody (34077) - 100μl | Login | Anti-Human MLH1 Antibody (34077) - 100μl | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD276 (B7-H3) (Mirzotamab) - 5.0 mg | Login | Anti-Human CD276 (B7-H3) (Mirzotamab) - 5.0 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD276 (B7-H3) (Mirzotamab) - 1.0 mg | Login | Anti-Human CD276 (B7-H3) (Mirzotamab) - 1.0 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD276 (B7-H3) (Mirzotamab) – Fc Muted™ - 500 µg | Login | Anti-Human CD276 (B7-H3) (Mirzotamab) – Fc Muted™ - 500 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD276 (B7-H3) (Mirzotamab) - 25 mg | Login | Anti-Human CD276 (B7-H3) (Mirzotamab) - 25 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD276 (B7-H3) (Mirzotamab) - 50 mg | Login | Anti-Human CD276 (B7-H3) (Mirzotamab) - 50 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD276 (B7-H3) (Mirzotamab) - 100 mg | Login | Anti-Human CD276 (B7-H3) (Mirzotamab) - 100 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 488 - 100 µg | Login | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 488 - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 488 - 200 µg | Login | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 488 - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 594 - 100 µg | Login | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 594 - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 594 - 200 µg | Login | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 594 - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 650 - 100 µg | Login | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 650 - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 650 - 200 µg | Login | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 650 - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR x MET (Amivantamab) - 1 mg | Login | Anti-Human EGFR x MET (Amivantamab) - 1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR x MET (Amivantamab) - 100 mg | Login | Anti-Human EGFR x MET (Amivantamab) - 100 mg | ||||||||||||||||
|
||||||||||||||||||


